Alumis (ALMS) Depreciation & Amortization (CF) (2023 - 2025)
Alumis (ALMS) reported Depreciation & Amortization (CF) of $867000.0 for Q4 2025, up 5.73% year-over-year from $820000.0 in Q4 2024, and down 5.35% quarter-over-quarter from $916000.0 in Q3 2025.
Alumis (ALMS) Depreciation & Amortization (CF) (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $867000.0 in Q4 2025.
- Depreciation & Amortization (CF) for Q4 2025 came in at $867000.0, up 5.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.5 million (up 10.91% YoY), and the FY2025 annual result was $3.5 million, up 10.91% from the prior year.
- Depreciation & Amortization (CF) fell to $867000.0 in Q4 2025 per ALMS's latest filing, from $916000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $916000.0 in Q3 2025 and troughed at $318000.0 in Q3 2023.
- A 3-year average of $769200.0 and a median of $817000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) jumped 155.97% in 2024, then rose 5.73% in 2025.
- A 3-year view of Depreciation & Amortization (CF) shows it stood at $726000.0 in 2023, then rose by 12.95% to $820000.0 in 2024, then climbed by 5.73% to $867000.0 in 2025.
- Business Quant data shows ALMS's Depreciation & Amortization (CF) at $867000.0 in Q4 2025, $916000.0 in Q3 2025, and $870000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 867,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 867,000.00 |
| Dec 31, 2025 | 867,000.00 |
| Sep 30, 2025 | 916,000.00 |
| Sep 30, 2025 | 916,000.00 |
| Jun 30, 2025 | 870,000.00 |
| Jun 30, 2025 | 870,000.00 |
| Mar 31, 2025 | 843,000.00 |
| Mar 31, 2025 | 843,000.00 |
| Dec 31, 2024 | 820,000.00 |
| Dec 31, 2024 | 820,000.00 |
| Sep 30, 2024 | 814,000.00 |
| Sep 30, 2024 | 814,000.00 |
| Jun 30, 2024 | 760,000.00 |
| Jun 30, 2024 | 760,000.00 |
| Mar 31, 2024 | 758,000.00 |
| Mar 31, 2024 | 758,000.00 |
| Dec 31, 2023 | 726,000.00 |
| Dec 31, 2023 | 726,000.00 |
| Sep 30, 2023 | 318,000.00 |
| Sep 30, 2023 | 318,000.00 |